Abstract
Mabinlin II is a thermostable sweet protein isolated from the mature seeds of Capparis masaikai Levl. grown in the subtropical region of the South of China. The Mabinlin II has been crystallized and diffraction data were collected to 1.7 Å resolution. The crystal belongs to space group C2 with unit cell parameters a = 80.11 Å, β = 51.08 Å, c = 47.34 Å, b = 122.77° .
Keywords: Sweet protein, Mabinlin II, Heat-stable protein, Capparis masaikai Levl., crystallization
Protein & Peptide Letters
Title: Crystallization and Preliminary X-Ray Analysis of the Highly Thermostable Sweet Protein Mabinlin II
Volume: 13 Issue: 3
Author(s): De-Feng Li, De-Yu Zhu, Zhong Hu and Da-Cheng Wang
Affiliation:
Keywords: Sweet protein, Mabinlin II, Heat-stable protein, Capparis masaikai Levl., crystallization
Abstract: Mabinlin II is a thermostable sweet protein isolated from the mature seeds of Capparis masaikai Levl. grown in the subtropical region of the South of China. The Mabinlin II has been crystallized and diffraction data were collected to 1.7 Å resolution. The crystal belongs to space group C2 with unit cell parameters a = 80.11 Å, β = 51.08 Å, c = 47.34 Å, b = 122.77° .
Export Options
About this article
Cite this article as:
Li De-Feng, Zhu De-Yu, Hu Zhong and Wang Da-Cheng, Crystallization and Preliminary X-Ray Analysis of the Highly Thermostable Sweet Protein Mabinlin II, Protein & Peptide Letters 2006; 13 (3) . https://dx.doi.org/10.2174/092986606775338443
DOI https://dx.doi.org/10.2174/092986606775338443 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy
Current Pharmaceutical Design Overcoming Endocrine Resistance in Breast Cancer
Current Cancer Drug Targets Uremic Toxins Elimination from Simulated Intestinal Serum with Mesopo-rous Silica Nanoparticles Coupled with Molecularly Imprinted Polymers and Amino Linker
Current Organic Synthesis Impact of Statin or Fibrate Therapy on Homocysteine Concentrations: A Systematic Review and Meta-analysis
Current Medicinal Chemistry Risk Reduction and Prevention of Alzheimer's Disease: Biological Mechanisms of Diet
Current Alzheimer Research New Look at Therapeutic Strategies for Blocking Costimulatory Signal in Experimental and Pre-Clinical Transplantation
Current Drug Safety New Inotropic Pharmacologic Strategies Targeting the Failing Myocardiumin the Newborn and Infant
Mini-Reviews in Medicinal Chemistry Pleiotropic Effects of Fenofibrate
Current Pharmaceutical Design Apoptosis Modulated by Oxidative Stress and Inflammation During Obstructive Nephropathy
Inflammation & Allergy - Drug Targets (Discontinued) The Role of Spiritual Health Experience with Intensity and Duration of Labor Pain While Childbearing and Postpartum
Current Women`s Health Reviews Pharmacological Inhibition of Poly(ADP-ribose) Polymerase in Cardiovascular Disorders: Future Directions
Current Vascular Pharmacology Therapy Against Ischemic Injury
Current Pharmaceutical Design Relationship between Compound α-Ketoacid and Microinflammation in Patients with Chronic Kidney Disease
Current Pharmaceutical Design Targeting CD4 to Disrupt Signaling Through Membrane Rafts: Towards a Raft-Based Therapeutics
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pulmonary Arterial Hypertension (PAH) Group 1: Overview, Workup, Risk Stratification, and Current (and Future) Treatment Approaches
Current Respiratory Medicine Reviews MicroRNAs Patents: The Road From Bench to Bedsides for Cancer Treatment
Recent Patents on DNA & Gene Sequences Microbiome Medicine: Microbiota in Development and Management of Cardiovascular Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Controlled Release Technologies for Chronotherapy: Current Status and Future Perspectives
Current Pharmaceutical Design Matrix Metalloproteinases and their Tissue Inhibitors in Diabetes, Atherosclerosis and Prediction of the Cardiovascular Risk
Current Enzyme Inhibition High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
Current Cardiology Reviews